Cardiol Therapeutics
CRDL
32 hedge funds and large institutions have $3.64M invested in Cardiol Therapeutics in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
3,300% more call options, than puts
Call options by funds: $34K | Put options by funds: $1K
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
23% more funds holding
Funds holding: 26 → 32 (+6)
3.11% more ownership
Funds ownership: 7.69% → 10.8% (+3.1%)
25% less capital invested
Capital invested by funds: $4.88M → $3.64M (-$1.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$671K |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$136K |
| 3 |
Goldman Sachs
New York
|
+$61.9K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$45.9K |
| 5 |
Jane Street
New York
|
+$38.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$36K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20K |
| 4 |
Morgan Stanley
New York
|
-$8.53K |
| 5 |
PO
Private Ocean
San Rafael,
California
|
-$3.35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
26
Rise Advisors
Rochester,
New York
| $510 | – | – | – |
|
|
SC
27
SouthState Corp
Winter Haven,
Florida
| $510 | +$610 | +1,000 | New |
|
|
NC
28
NewSquare Capital
Newtown Square,
Pennsylvania
| $357 | +$427 | +700 | New |
|
|
OLVIG
29
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $255 | – | – | – |
|
|
TCM
30
Tradewinds Capital Management
Bellingham,
Washington
| $255 | – | – | – |
|
31
Group One Trading
Chicago,
Illinois
| $1 | +$1 | +1 | New |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$28.2K | -46,204 | Closed |
|
|
33
Millennium Management
New York
| – | -$36K | -34,543 | Closed |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20K | -19,226 | Closed |
|
|
MOS
35
MGO One Seven
Beachwood,
Ohio
| – | -$10 | -10,000 | Closed |
|
36
Bank of America
Charlotte,
North Carolina
| – | -$1K | -1,399 | Closed |
|
CRDL Hedge Fund Activity: Q4 2022 in Review
32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q4 2022, worth a combined $3.64M — down 25% from $4.88M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CRDL positions and 5 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $671K. The largest seller was Millennium Management, exiting entirely with an estimated $36K sold.
- 32 institutional investors held Cardiol Therapeutics (CRDL) as of Q4 2022, up from 26 in Q3 2022.
- Funds reported $3.64M of Cardiol Therapeutics stock for Q4 2022, down 25% quarter-over-quarter.
- 11 funds opened new Cardiol Therapeutics positions in Q4 2022 and 5 closed out, a net change of +6 holders.
- The largest Cardiol Therapeutics buyer in Q4 2022 was AdvisorShares Investments, an estimated $671K added.
- The largest Cardiol Therapeutics seller in Q4 2022 was Millennium Management, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2022.